Clinical Trials Browser

Phase 2 × MSI-H Advanced Colorectal Cancer × Immune Checkpoint Inhibitors × Clear all

NCT05035381 2021-09-05

PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer

Phase 2 Unknown

GastrointestinalOther solid neoplasm

MSI-H Advanced Colorectal Cancer